Sponsor:
Janssen Research & Development, LLC
Code:
NCT05455320
Conditions
Relapsed or Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Talquetamab
Daratumumab
Pomalidomide
Dexamethasone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations